Colon Cancer Clinical Trial

Systems of Support (SOS) to Increase Colon Cancer Screening and Follow-up Supplement

Summary

Ancillary Aim #1 We will evaluate intervention effects by comparing binary outcomes for screening (yes/no) in the primary SOS study. In this aim, we propose to calculate actual screening rates by use of time-to-event analyses (also known as survival analysis). The outcome variable of interest is the first time since randomization to have CRCS, either based on FOBT, FS, or CS. Knowing screening rates will not only enable us to make comparisons between groups, but also over time.

Ancillary Aims #2 and #3 We will recruit additional participants for two ancillary study aims. First, we will enroll patients age 50-74 years using the same criteria as for the primary SOS study, which includes neither history of colorectal cancer nor evidence of life-limiting disease. Participants who return the questionnaire, consent and considered eligible will be randomized to receive one of three different at-home fecal test kits. The kits will be returned to the GH centralized laboratory, and participants will be informed about lab results using standard GH pathways. Participants who have a test-positive will receive a series of two follow-up surveys (first at 1-2 weeks post result and second at 4-months post result). A comparison group of test-negative results will be matched based on selected criteria, and this group will also receive the follow-up surveys. Participants at both time intervals who do not return the survey via mail will be called and if available, administered the questionnaire via phone.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Not up to date on CRCS
Continuously enrolled in GHC for 24 months
Expected to continue to be enrolled at GHC for 24 months

Exclusion Criteria:

Known high risk for CRC
History of CRC
History of inflammatory bowel disease
Current anticoagulation therapy
Organ failure
Serious illness
Debilitating disease
Dementia
Nursing home resident.

Study is for people with:

Colon Cancer

Estimated Enrollment:

2260

Study ID:

NCT01052922

Recruitment Status:

Completed

Sponsor:

Kaiser Permanente

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Kaiser Permanente Washinton Health Research Institute
Seattle Washington, 98101, United States

How clear is this clinincal trial information?

Study is for people with:

Colon Cancer

Estimated Enrollment:

2260

Study ID:

NCT01052922

Recruitment Status:

Completed

Sponsor:


Kaiser Permanente

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider